Breaking Barriers — The Future of Repurposed Drugs in Cancer Therapy

Table of Contents:

• Introduction: Rethinking the Path to Cancer Cures
• Why Repurposed Drugs Matter
• The Courage Against Cancer Preclinical Study
• Overcoming Institutional Resistance
• A Call for Courage — and Community Support

---

Introduction: Rethinking the Path to Cancer Cures

Modern oncology has made great strides, but the staggering cost of new cancer drugs and their limited accessibility leave millions without hope. At Courage Against Cancer (CAC), we believe the future lies in reimagining what’s already in our medicine cabinet. Repurposed drugs — safe, inexpensive, and well-understood — could offer a faster, more inclusive route to healing.

---

Why Repurposed Drugs Matter

Repurposed therapies like ivermectin and mebendazole have shown promising anti-cancer mechanisms in preclinical research — including the ability to disrupt tumor metabolism, inhibit angiogenesis, and trigger apoptosis in resistant cancer cells. Unlike novel compounds, these drugs already have established safety profiles, which can drastically reduce development timelines and costs.

For patients fighting aggressive cancers, that difference can mean years of life gained.

---

The Courage Against Cancer Preclinical Study

CAC’s first major research initiative focuses on ivermectin and mebendazole against ovarian cancer, conducted through the Sood Lab at MD Anderson. This study represents a crucial first step toward FDA recognition of repurposed anti-cancer therapies.

By establishing molecular pathways and confirming tumor suppression effects in lab models, this research could pave the way for early-phase clinical trials — and open a new era of low-cost, science-based cancer care.

---

Overcoming Institutional Resistance

Despite growing global interest, research on nontraditional cancer treatments faces major obstacles: limited funding, regulatory barriers, and public skepticism. CAC exists to challenge that status quo. We’re building partnerships with medical researchers, patient advocates, and donors who believe that healing should not be reserved for the wealthy — but should be a human right supported by courage and compassion.

---

A Call for Courage — and Community Support

Every discovery begins with courage — the courage to question, to test, and to believe that better treatments are possible. Our foundation is powered by ordinary people who dare to make an extraordinary difference.

---

💙 Support Our Mission

Every day, thousands of families face cancer with limited options — but your generosity can change that. By donating to Courage Against Cancer (CAC), you help fund real scientific research into non-traditional, affordable, and repurposed cancer therapies like ivermectin and mebendazole. Our mission is to bring hope and healing where conventional systems have fallen short — by advancing evidence-based, natural, and alternative therapies toward FDA-recognized validation.

Every contribution, large or small, directly supports our ongoing preclinical study on ovarian cancer, educational outreach, and future clinical trial development.
✨ Join us in transforming courage into cures.

---

Disclaimer: The Courage Against Cancer Foundation provides scientific information for educational purposes only. This is not medical advice. We strongly advocate that all treatment decisions be made in consultation with a qualified healthcare provider. Do not start or stop any treatment without professional medical guidance.

Conclusion

The high cost and long timelines of developing entirely new cancer drugs are real barriers that repurposed therapies like ivermectin and mebendazole could help address, provided the research gets the funding and institutional support it needs to move forward. Courage Against Cancer’s ovarian cancer study is one attempt to close that gap directly.

Overcoming institutional and funding obstacles is a genuine challenge, but it doesn’t change the underlying scientific standard: these drugs still need to prove themselves through the same rigorous trial process required of any cancer therapy. Supporting this research means supporting that process, not shortcuts around it — and patients should continue relying on their oncology team’s guidance while it unfolds.

---

---

Medical Disclaimer

This article is produced by Courage Against Cancer (CAC) for educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. No information presented here should be used to initiate, modify, or discontinue any cancer therapy without first consulting a qualified oncologist or licensed healthcare provider. Courage Against Cancer (CAC) does not endorse any specific treatment protocol.